FIELD: medicine. SUBSTANCE: method involves solving human insulin substance of activity equal to at least 27.5 ED/mg is solved in acid aqueous medium in zinc ions presence until their total concentration in the preparation reaches 25-30 mcg per 100 ED of insulin. Then inhibitor solution produced by dissolving Nypagin in water for injections at room temperature and pH 9.0-11.0 is added under constant stirring. Then, solution of trihydrate of sodium acetate and glycerol is added, solution pH is adjusted to 7.3-7.5 and sterilizing filtration is carried out. The produced solution is hold during 15-20 days at 2-8 C and repeatedly filtered. EFFECT: highly effective stable preparation. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION SOLUTION BASED ON SUBSTANCE OF HUMAN GENE ENGINEERED (RECOMBINANT) INSULIN | 2004 |
|
RU2275189C1 |
METHOD OF PREPARING PHARMACEUTICAL COMPOSITION SOLUTION BASED ON SUBSTANCE OF GENE ENGINEERING (RECOMBINANT) HUMAN INSULIN | 2001 |
|
RU2184533C1 |
METHOD OF PREPARING "PENSULIN CP" PREPARATION OF INSULIN SOLUTION FOR CARTRIDGE | 1999 |
|
RU2157238C1 |
COMPOSITION FOR KILLING TNF-α-SENSITIVE TUMOR CELLS | 2002 |
|
RU2209078C1 |
METHOD OF PREPARING OF INSULIN AQUEOUS SOLUTION | 1992 |
|
RU2020954C1 |
METHOD OF PREPARING RECOMBINANT THYMIDINE PHOSPHORYLASE, RECOMBINANT PLASMID DNA PERTPHO1 AND STRAIN ESCHERICHIA COLI BL21(DE3)/PERTPHO1 AS PRODUCER OF THYMIDINE PHOSPHORYLASE | 2000 |
|
RU2188234C2 |
PEPTIDES SHOWING REGENERATIVE-REPARATIVE ACTION | 1994 |
|
RU2065445C1 |
METHOD OF ISOLATION OF GENOME DNA FROM MICROORGANISM CELLS | 2000 |
|
RU2185440C2 |
METHOD OF PREPARING PREPARATION "PENSULIN CC" OF INSULIN SUSPENSION FOR CARTRIDGE | 1999 |
|
RU2157698C1 |
METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION SUSPENSION BASED ON SUBSTANCE OF HUMAN GENETIC ENGINEERING (RECOMBINANT) INSULIN | 2004 |
|
RU2281756C2 |
Authors
Dates
2003-04-20—Published
2001-07-20—Filed